Procter & Gamble Company (The)$146.57NFLX · NASDAQ-GS
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $45.18B | $39.00B | $33.72B | $31.62B | $29.70B | $25.00B | $20.16B | $15.79B |
| Cost of Revenue | $23.28B | $21.04B | $19.72B | $19.17B | $17.33B | $15.28B | $12.44B | $9.97B |
| Research & Development | $3.39B | $2.93B | $2.68B | $2.71B | $2.27B | $1.83B | $1.67B | $1.22B |
| Selling, General & Administrative | $1.89B | $1.70B | $1.72B | $1.57B | $1.35B | $1.08B | $914.37M | $630.29M |
| Operating Income | $13.33B | $10.42B | $6.95B | $5.63B | $6.19B | $4.59B | $2.60B | $1.61B |
| Interest Expense | — | — | $699.83M | $706.21M | $765.62M | $767.50M | $626.02M | $420.49M |
| Other Income / (Expense) | $172.46M | $266.78M | -$48.77M | $337.31M | $411.21M | -$618.44M | $84.00M | $41.73M |
| Income Before Taxes | $12.72B | $9.97B | $6.21B | $5.26B | $5.84B | $3.20B | $2.06B | $1.23B |
| Provision for Income Taxes | $1.74B | $1.25B | $797.41M | $772.00M | $723.88M | $437.95M | $195.31M | $15.22M |
| Net Income | $10.98B | $8.71B | $5.41B | $4.49B | $5.12B | $2.76B | $1.87B | $1.21B |
| Basic EPS | $2.58 | $2.03 | $1.22 | $10.10 | $11.55 | $6.26 | $4.26 | $2.78 |
| Diluted EPS | $2.53 | $1.98 | $1.20 | $9.95 | $11.24 | $6.08 | $4.13 | $2.68 |
| Basic Shares Outstanding | 4.25B | 4.30B | 4.42B | 444.70M | 443.15M | 440.92M | 437.80M | 435.37M |
| Diluted Shares Outstanding | 4.34B | 4.39B | 4.49B | 451.29M | 455.37M | 454.21M | 451.76M | 451.24M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $3.59 | $3.55 | $3.68 | 14 | ↑5 ↓8 |
| Dec 2027 | $3.83 | $3.60 | $4.09 | 14 | ↑4 ↓8 |
| Dec 2028 | $4.60 | $4.20 | $5.08 | 8 | ↑2 ↓0 |
| Dec 2029 | $5.25 | $4.58 | $6.29 | 4 | ↑1 ↓0 |
